314 related articles for article (PubMed ID: 18315582)
21. Homocysteine in the context of cobalamin metabolism and deficiency states.
Briddon A
Amino Acids; 2003; 24(1-2):1-12. PubMed ID: 12624731
[TBL] [Abstract][Full Text] [Related]
22. Association of aspirin use with vitamin B12 deficiency (results of the BACH study).
van Oijen MG; Laheij RJ; Peters WH; Jansen JB; Verheugt FW;
Am J Cardiol; 2004 Oct; 94(7):975-7. PubMed ID: 15464695
[TBL] [Abstract][Full Text] [Related]
23. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.
Valuck RJ; Ruscin JM
J Clin Epidemiol; 2004 Apr; 57(4):422-8. PubMed ID: 15135846
[TBL] [Abstract][Full Text] [Related]
24. The limited value of methylmalonic acid, homocysteine and holotranscobalamin in the diagnosis of early B12 deficiency.
Goringe A; Ellis R; McDowell I; Vidal-Alaball J; Jenkins C; Butler C; Worwood M
Haematologica; 2006 Feb; 91(2):231-4. PubMed ID: 16461308
[TBL] [Abstract][Full Text] [Related]
25. Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome.
Ströker E; Leone L; Vandeput Y; Borbath I; Lefebvre C
Acta Clin Belg; 2014; 69(1):62-5. PubMed ID: 24635401
[TBL] [Abstract][Full Text] [Related]
26. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
[TBL] [Abstract][Full Text] [Related]
27. Do acid-lowering agents affect vitamin B12 status in older adults?
Dharmarajan TS; Kanagala MR; Murakonda P; Lebelt AS; Norkus EP
J Am Med Dir Assoc; 2008 Mar; 9(3):162-7. PubMed ID: 18294598
[TBL] [Abstract][Full Text] [Related]
28. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
29. [Vitamin B12 deficiency: a challenging diagnosis and treatment].
Rufenacht P; Mach-Pascual S; Iten A
Rev Med Suisse; 2008 Oct; 4(175):2212-4, 2216-7. PubMed ID: 19024576
[TBL] [Abstract][Full Text] [Related]
30. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
Laine L; Shah A; Bemanian S
Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
[TBL] [Abstract][Full Text] [Related]
31. Cobalamin profiles in patients after urinary diversion.
Sagalowsky AI; Frenkel EP
J Urol; 2002 Apr; 167(4):1696-700. PubMed ID: 11912390
[TBL] [Abstract][Full Text] [Related]
32. Costs and risks in the management of patients with gastric acid hypersecretion.
Hirschowitz BI; Fineberg N; Wilcox CM; Mohnen J; Worthington J
J Clin Gastroenterol; 2010 Jan; 44(1):28-33. PubMed ID: 19581810
[TBL] [Abstract][Full Text] [Related]
33. No influence of age and gastric acid secretion on serum vitamin B12 concentration.
Schepp W; Lindstaedt H; Miederer SE; Elster K
Hepatogastroenterology; 1980 Aug; 27(4):294-9. PubMed ID: 7203366
[TBL] [Abstract][Full Text] [Related]
34. [Can a vitamin B12 deficiency in PPI intake be offset by an increased intake of oral B12?].
Radziwill R
Med Monatsschr Pharm; 2014 Aug; 37(8):299. PubMed ID: 25158379
[No Abstract] [Full Text] [Related]
35. Folate, vitamin B12 and homocysteine status in women of childbearing age: baseline data of folic acid wheat flour fortification in Iran.
Abdollahi Z; Elmadfa I; Djazayeri A; Sadeghian S; Freisling H; Mazandarani FS; Mohamed K
Ann Nutr Metab; 2008; 53(2):143-50. PubMed ID: 18997463
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: a retrospective review.
Baz R; Alemany C; Green R; Hussein MA
Cancer; 2004 Aug; 101(4):790-5. PubMed ID: 15305411
[TBL] [Abstract][Full Text] [Related]
37. Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency?
ter Heide H; Hendriks HJ; Heijmans H; Menheere PP; Spaapen LJ; Bakker JA; Forget PP
J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):342-5. PubMed ID: 11593135
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin neurotoxicity: failure to demonstrate vitamin B12 inactivation.
Trugman J; Hogenkamp HP; Roelofs R; Hrushesky WJ
Cancer Treat Rep; 1985 Apr; 69(4):453-5. PubMed ID: 4039629
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of vitamin B12 deficiency--an update.
Hvas AM; Nexo E
Haematologica; 2006 Nov; 91(11):1506-12. PubMed ID: 17043022
[TBL] [Abstract][Full Text] [Related]
40. [Risk of long-term treatment with proton pump inhibitors].
Mathieu N
Rev Prat; 2008 Sep; 58(13):1451-4. PubMed ID: 18924330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
